CPQ total | Oral symptoms | Functional limitations | Emotional well-being | Social well-being | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
na | Medianb (P10-P90) | Meanc (SD) | Preva-lence (%)d | Extente | Medianb (P10-P90) | Meanc (SD) | Preva-lence (%)d | Extente | Medianb (P10-P90) | Meanc (SD) | Preva-lence (%)d | Extente | Medianb (P10-P90) | Meanc (SD) | Preva- lence (%)d | Extente | Medianb (P10-P90) | Meanc (SD) | Preva-lence (%)d | Extente | |
IOM group | 173 | 4 (0–18) | 6.0 (8.0) | 5.5 | 0.12 | 2 (0–5) | 2.4 (2.3) | 3.5 | 0.04 | 1 (0–6) | 2.1 (3.4) | 5.4 | 0.07 | 0 (0–3.5) | 0.9 (2.9) | 1.2 | 0.02 | 0 (0–2) | 0.7 (2.4) | 0.6 | 0.01 |
Boys | 96 | 4 (0–20) | 7.0 8.9 | 7.6 | 0.18 | 2 (0–6) | 2.8 (2.4) | 4.3 | 0.05 | 1 (0–8) | 2.3 (3.5) | 6.5 | 0.09 | 0 (0–4) | 1.0 (3.1) | 2.1 | 0.03 | 0 (0–2) | 0.8 (2.5) | 1.0 | 0.01 |
Girls | 72 | 4.5 (0–16) | 7.6 (8.9) | 2.9 | 0.03 | 2 (0–6) | 2.8 (2.4) | 2.8 | 0.03 | 1 (0–9) | 2.8 (3.7) | 4.3 | 0.06 | 0 (0–5) | 1.2 (2.9) | 0 | 0 | 0 (0–6) | 1.2 (2.8) | 0 | 0 |
Control group | 95 | 4 (0–14) | 5.9 (7.2) | 4.4 | 0.05 | 2 (0–6) | 2.5 (2.2) | 3.2 | 0.04 | 0 (0–7) | 2.1 (3.0) | 1.1 | 0.01 | 0 (0–2) | 0.9 (2.2) | 0 | 0 | 0 (0–2) | 0.7 (2.0) | 0 | 0 |
Boys | 48 | 4 (0.11) | 4.6 (5.0) | 2.1 | 0.02 | 2 (0–6) | 2.4 (2.0) | 2.1 | 0.02 | 0 (0–6) | 1.5 (2.3) | 0 | 0 | 0 (0–2) | 0.6 (1.5) | 0 | 0 | 0 (0–0) | 0.2 (0.7) | 0 | 0 |
Girls | 44 | 2 (0–13 | 4.6 (6.1) | 7.1 | 0.10 | 2 (0–4) | 1.9 (2.0) | 4.7 | 0.07 | 0 (0–5) | 1.9 (3.3) | 2.3 | 0.02 | 0 (0–2) | 0.7 (2.5) | 0 | 0 | 0 (0–0) | 0.5 (2.0) | 0 | 0 |